This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03156/identifier/chebi/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03156/identifier/wikipedia/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03156/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03156/identifier/kegg-compound/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03156/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03156
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB03156 n14:DB03156
dcterms:title
D-Glucuronic Acid
adms:identifier
n9:Glucuronic_acid n10:DB03156 n11:C00191 n12:35182 n13:BDP
n3:synonym
Glucosiduronate GCU D-(+)-glucuronic acid D-(+)-glucuronate alpha-delta-glucuronic acid alpha-delta-glucopyranuronic acid Glucuronic acid alpha-D-glucuronic acid delta-(+)-glucuronic acid Glucuronate alpha-D-glucopyranuronic acid delta-(+)-glucuronate D-glucuronate Glucosiduronic acid delta-glucuronate
n3:synthesisReference
Gerhard Weber, Karlheinz Schrader, "D-glucuronic acid-urea condensate preparation for smoothing human skin." U.S. Patent US4703041, issued October 27, 1987.
n3:IUPAC-Name
n4:271B5459-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B545F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B545E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B545B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B545C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B545D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5457-363D-11E5-9242-09173F13E4C5 n4:271B546F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5458-363D-11E5-9242-09173F13E4C5 n4:271B5455-363D-11E5-9242-09173F13E4C5 n4:271B5471-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5456-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5465-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5466-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5460-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5461-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5463-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5462-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5464-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
6556-12-3
n3:Bioavailability
n4:271B546B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B546D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B546E-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5470-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B546A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5469-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B546C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B545A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5467-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5468-363D-11E5-9242-09173F13E4C5